FREM2 and central nervous system cancer: When the “old” classification was used, the expression of CRNDE, FREM2, and SPRY genes allowed the diagnosis of “glioblastoma, grade IV” to be differentiated from the lower grade gliomas (astrocytomas, oligoastrocytomas, and oligodendrogliomas).